GGrantIndex
Sort

46,585 grants matching heart failure

1/1: ARREST RESPIRATORY FAILURE DUE TO PNEUMONIA (ARREST PNEUMONIA)

$1,581,887
Joseph Eric Levitt · Stanford University · UH3 · FY2023 · HL

A longitudinal cohort study to evaluate cardiovascular risk factors and disease in Haiti - 2

$1,581,146
Margaret Leighton McNairy · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · HL

Initiation of a cohort to define pathogenic Mechanisms, Precision diagnosis And Complications of Thrombotic Microangiopathies: The IMPACT Study

$1,580,963
Robert A Brodsky · Johns Hopkins University · U54 · FY2025 · HL

The Genetics of Uveal Coloboma

$1,580,798
Brian Brooks · National Eye Institute · ZIA · FY2014 · EY

National Sleep Research Resource (NSRR)

$1,580,311
Susan S Redline · Brigham And Women'S Hospital · R24 · FY2015 · HL

SPECIALIZED CENTER OF RESEARCH IN HEART FAILURE

$1,579,771
Brigham And Women'S Hospital · P50 · FY2002 · HL

Gene Therapy:Translating Basic Science to the Clinic

$1,579,670
University Of California San Diego · P01 · FY2001 · HL

Aptamer Proteomics of Cardiometabolic and Renal Traits in African Americans

$1,579,430
James Graham Wilson · University Of Mississippi Med Ctr · R01 · FY2017 · HL

CHS research resources for the cardiovascular health of older adults

$1,577,728
Bruce M Psaty · University Of Washington · U01 · FY2016 · HL

Genetically-engineered pig organ transplantation in baboons: immunological and functional studies

$1,576,760
David Kc Cooper · Massachusetts General Hospital · U19 · FY2023 · AI

Genetically-engineered pig organ transplantation in baboons: immunological and functional studies

$1,576,760
David Kc Cooper · Massachusetts General Hospital · U19 · FY2024 · AI

SPECIALIZED CENTER OF RESEARCH IN HEART FAILURE

$1,576,475
Baylor College Of Medicine · P50 · FY2002 · HL

Targeting resitin and RELM-beta to treat pulmonary hypertension

$1,576,472
Roger A Johns · Johns Hopkins University · UH2 · FY2015 · HL

HLS- A Phase 1 Open-Label Dose-Escalation with Expansion Study of SX-682 in MDS Patients

$1,575,472
Stuart J Kahn · Syntrix Biosystems, Inc. · R44 · FY2020 · HL

Strategies to Optimize Pig-to-Primate Kidney Xenograft Survival

$1,575,160
Andrew B Adams · University Of Minnesota · U01 · FY2025 · AI

Investigations of Methylmalonic Acidemia and Related Disorders

$1,574,328
Charles P Venditti · National Human Genome Research Institute · ZIA · FY2020 · HG

Blood Pressure and ADRD in African Americans: the Jackson Heart Study

$1,574,198
Priya Palta · Columbia University Health Sciences · R01 · FY2019 · AG

Genetic risks for ALI in ARDSnet and the iSPAAR Consortium

$1,573,218
Mark M Wurfel · University Of Washington · RC2 · FY2010 · HL

National Sleep Research Resource (NSRR)

$1,572,108
Susan S Redline · Brigham And Women'S Hospital · R24 · FY2016 · HL

TRANSFORM-HF CCC

$1,570,848
Eric J Velazquez · Yale University · U01 · FY2020 · HL

Mechanism of oxidative/nitrosative stress and inflammation-induced tissue injury

$1,570,521
Pal Pacher · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2016 · AA

The Center for Advancing Point of Care in Heart, Lung, Blood and Sleep Diseases

$1,570,233
David D. McManus · Univ Of Massachusetts Med Sch Worcester · U54 · FY2020 · HL

Expression Genetics in Drug Therapy

$1,570,156
Wolfgang Sadee · Ohio State University · U01 · FY2011 · GM

BMT Survivor Study-2 (BMTSS-2)

$1,569,615
Smita Bhatia · University Of Alabama At Birmingham · U01 · FY2020 · CA

The first clinical use of the BiVACOR Total Artificial Heart

$1,569,477
Daniel Timms · Bivacor, Inc. · R44 · FY2023 · HL